Should I Buy Procter & Gamble (PG)? Finance YouTuber Analysis

The YouTuber suggests Proctor & Gamble as a company possessing strong pricing power, enabling it to transfer higher costs to customers without losing significant market share. This characteristic is crucial for maintaining profit margins in an inflationary and high-interest-rate environment.

“Think about companies like Coca-Cola or Proctor Gamble. If their costs go up, they just pass those costs on. People don't stop buying their toothpaste or soda just because those prices go up a little.”

The YouTuber suggests Procter & Gamble as a potential rebound candidate within consumer staples. Despite years of inflation and tariffs impacting the group, he believes valuations are currently too low to ignore and the company maintains stable cash flows, making it a good value for long-term investors.

“That means stocks like General Mills, ticker GIS, Proctor and Gamble, PG and Clorox, CLX could be good rebound candidates.”

The analyst suggests Procter & Gamble and the consumer staples sector might be 'dead money' in 2023, as their valuations are high (PG trades at a 12% premium to its 5-year average P/S ratio) and expected revenue and earnings growth are flat. He believes investors will shift to higher-growth stocks unless there's another market crash, which would then make these defensive stocks attractive again.

“so unless the rest of the market just kind of falls apart again this year I think PNG and really the rest of the consumer staples sector are going to be kind of dead money you know you're going to get a lot of investors leaving stocks in this sector for those higher growth stocks if the market continues to go higher it's only going to be if we see another stock market crash that people are going to seek for safety in these in these consumer staple stocks”

Hogue recommends avoiding Procter & Gamble, citing that consumer staples companies struggle to raise prices sufficiently to cover increased production costs in a competitive market. This pressure on profit margins is expected to continue, making them a less attractive investment.

“So I think you avoid stocks like Clorox, Procter & Gamble, and Kellogg.”

The analyst, while personally preferring Unilever, acknowledges Procter & Gamble as a reliable dividend aristocrat suitable for investors prioritizing dividend income. The dividend is secure and expected to grow, and the stock shows a fair value based on cash flow and earnings, with a projected annual return potential of over 10%.

“Die decken die Dividende beide ist auch ein Dividendenarchistokrat und da muss man sich keine Sorgen machen. Guck uns mal die Multiples an und dann siehst du auch recht volatil hier der Aktienkurs.”

The YouTuber advises against investing heavily in Procter & Gamble, citing its currently elevated valuation. He contrasts its lower growth potential with tech stocks and suggests that its 'safe haven' status has led to a price that offers limited future returns. He also points out that such traditional value companies are more exposed to supply chain issues and the direct impact of inflation on their operational costs.

“ich wäre vorsichtig jetzt ein großteil des vermögens da rein zu schieben weil ich mir sage ja das ist das sichere hafen weil die bewertung sind da ist schon wieder so hoch dass ich nicht glaube dass man da ist noch unbedingt viel rendite mit macht und vielleicht gibt es dann auch da eine korrektur”

The YouTuber includes Procter & Gamble in a list of stocks that are trading at 'ridiculously high prices' for their quality, aligning with Howard Marks' concern about the overvaluation of average companies in the US market.

“Proctor and Gamble is the same thing.”

The YouTuber advises avoiding Procter & Gamble due to three red flags: declining gross profit margins since 2010, stagnant revenue growth indicating a loss of distribution power against new competition, and a significant debt load of $37 billion which will become more expensive to service as interest rates rise. These factors combined with a high valuation of 25 times earnings for a no-growth company make it an unattractive investment.

“I think this ultimately puts Procter and Gamble in a much more difficult position than investors are thinking right now the stock trades for about 25 times earnings that's a very high multiple for a no growth company that doesn't have a lot of opportunities to grow the bottom line in the future.”